# Introduction

This project analyzes the results of a randomized A/B test designed to
evaluate whether a new product experience improves user conversion rates.

The primary objective of the experiment is to determine whether the
treatment increases conversion relative to the existing experience.

Beyond measuring statistical significance, the analysis also evaluates
the practical consistency and robustness of the observed treatment
effect across different user groups.


# Experiment Design

The experiment follows a randomized A/B testing framework in which users
were assigned to either a control group or a treatment group.

The control group represents the existing product experience, while the
treatment group represents the proposed variation being evaluated.

The primary metric of interest is conversion rate, defined as the
proportion of users who completed the target action.

Additionally, purchase amount is analyzed as a guardrail metric to ensure
that improvements in conversion are not associated with negative effects
on user spending behavior.

The analysis focuses on:
- validating the integrity of the experiment
- measuring the magnitude of the treatment effect
- evaluating statistical significance
- assessing robustness across user segments


# Experiment Validation

Before interpreting experimental results, it is important to verify that
the randomization process produced comparable groups.

Several validation procedures were performed, including:
- Sample Ratio Mismatch (SRM) analysis
- covariate balance testing
- temporal consistency analysis

No evidence of sample ratio mismatch was detected, indicating that the
observed allocation between control and treatment groups is consistent
with the expected experimental design.

Additionally, no statistically significant imbalance was found across
observed user characteristics such as:
- age
- gender
- device type
- location
- session duration

Temporal consistency analysis also provided no evidence that treatment
assignment varied systematically over time.

Overall, the validation results support the assumption that treatment
assignment is independent of observed user characteristics, reinforcing
the validity of causal inference.


# Statistical Results

The treatment group achieved a substantially higher conversion rate than
the control group.

Conversion increased from approximately 11.9% in the control group to
18.0% in the treatment group.

This corresponds to:
- an absolute uplift of approximately 6 percentage points
- a relative uplift of approximately 51%

Statistical testing produced considerably small p-values, providing strong
evidence against the null hypothesis of equal conversion rates.

A 95% confidence interval for the treatment effect also excluded zero,
further supporting the conclusion that the observed uplift is unlikely
to be explained by random variation alone.

Overall, the results suggest that the treatment produces a meaningful
positive effect on conversion performance.


# Guardrail Metric Analysis

In addition to conversion rate, purchase amount was analyzed as a
guardrail metric.

The objective of this analysis is to ensure that improvements in
conversion are not accompanied by undesirable effects on user spending
behavior.

The treatment group also achieved higher average revenue per user (ARPU)
relative to the control group.

Average purchase amount increased from approximately 4.45 in the control
group to 6.76 in the treatment group, corresponding to a relative
increase of approximately 52%.

Statistical testing indicates that the observed difference is unlikely
to be explained by random variation alone.

These results suggest that the treatment not only improves conversion
performance, but also increases revenue-related metrics.


# Segmentation Analysis

Additional analyses were performed to evaluate whether the treatment
effect remained consistent across different user segments.

The treatment effect was examined separately across:
- device types
- gender categories
- geographic locations

Positive uplifts were observed across all evaluated segments, with
moderate variation in effect magnitude.

To further evaluate treatment heterogeneity, a logistic regression model
with interaction terms was fitted using device type as a representative
segmentation variable.

The objective of this analysis was to assess whether the treatment
effect differed meaningfully across desktop, mobile, and tablet users.

No statistically significant interaction effects were detected for the
evaluated device categories.

These results suggest that the observed treatment effect is reasonably
stable across the analyzed user segments rather than being concentrated
within a single subgroup.


# Final Recommendation

The analysis provides strong evidence that the treatment improves both
conversion performance and revenue-related metrics relative to the
control group.

The observed uplift appears statistically significant, practically
meaningful, and reasonably consistent across the evaluated user
segments.

Under the assumptions of the experiment, the results support deploying
the treatment as a replacement for the current experience.

In a real production environment, continued monitoring after deployment
would still be recommended to verify that the observed effects remain
stable over time and continue to generalize to broader user populations.